A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: Implication for structure and active site binding mechanism

Conference proceedings article


Authors/Editors


Strategic Research Themes

No matching items found.


Publication Details

Author listPhakthanakanok K., Ratanakhanokchai K., Kyu K.L., Sompornpisut P., Watts A., Pinitglang S.

PublisherBioMed Central

Publication year2009

Volume number10

Issue numberSUPPL. 1

ISSN1471-2105

eISSN1471-2105

URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-60849087677&doi=10.1186%2f1471-2105-10-S1-S48&partnerID=40&md5=9d28b5ec247499b952204d59a228649d

LanguagesEnglish-Great Britain (EN-GB)


View in Web of Science | View on publisher site | View citing articles in Web of Science


Abstract

Background: SARS coronavirus main proteinase (SARS CoVMpro) is an important enzyme for the replication of Severe Acute Respiratory Syndrome virus. The active site region of SARS CoVMpro is divided into 8 subsites. Understanding the binding mode of SARS CoVMpro with a specific substrate is useful and contributes to structural-based drug design. The purpose of this research is to investigate the binding mode between the SARS CoVMpro and two octapeptides, especially in the region of the S3 subsite, through a molecular docking and molecular dynamics (MD) simulation approach. Results: The one turn α-helix chain (residues 47-54) of the SARS CoVMpro was directly involved in the induced-fit model of the enzyme-substrate complex. The S3 subsite of the enzyme had a negatively charged region due to the presence of Glu47. During MD simulations, Glu47 of the enzyme was shown to play a key role in electrostatic bonding with the P3Lys of the octapeptide. Conclusion: MD simulations were carried out on the SARS CoVMpro-octapeptide complex. The hypothesis proposed that Glu47 of SARS CoVMpro is an important residue in the S3 subsite and is involved in binding with P3Lys of the octapeptide. © 2009 Phakthanakanok et al; licensee BioMed Central Ltd.


Keywords

No matching items found.


Last updated on 2023-29-09 at 10:26